We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Nanoparticle Developed To Tackle Leukemia Treatment Resistance

News   Jun 19, 2020 | Original story from University of Connecticut

 
Nanoparticle Developed To Tackle Leukemia Treatment Resistance

Credit: NCI Visuals

 
 
Advertisement
 

RELATED ARTICLES

UK Government-Funded COVID-19 Vaccine Phase 1/2 Trials Report Positive Data

News

A new COVID-19 vaccine candidate – VLA2001 – developed by Valneva has shown positive results in a UK Government-funded Phase I/II clinical trial, according to a press release.

READ MORE

Molecular Devices Opens Organoid Innovation Center

News

Molecular Devices, LLC., has opened an Organoid Innovation Center at the company’s global headquarters. The center expands beyond imaging to demonstrate an end-to-end solution that addresses challenges associated with every step in the sample prep-to-report pipeline for assays performed on complex 3D biological models.

READ MORE

Optimizing Antibody Drug Development With Machine Learning

News

Scientists have designed a machine learning approach that supports the optimization stage of therapeutic antibody development.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE